Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/32412
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Zhang, Boyang | - |
dc.contributor.author | Hollinger, Andrew | - |
dc.date.accessioned | 2025-09-24T20:17:49Z | - |
dc.date.available | 2025-09-24T20:17:49Z | - |
dc.date.issued | 2025 | - |
dc.identifier.uri | http://hdl.handle.net/11375/32412 | - |
dc.description.abstract | This thesis presents the development and validation of a novel in vitro vascularized liver spheroid. The device improved upon two micropatterning techniques previously developed in our lab: extrusion-based 3D printing to create sacrificial scaffolds to form a vascular channel, and microcontact printing using a stamp to imprint a scaffold on the surface of the hydrogel. This study redesigned the stamp to facilitate the precise positioning of hepatic spheroids of varying sizes within a fibrin hydrogel. Furthermore, a novel bifurcating vascular channel scaffold was designed to surround the embedded hepatic spheroid. Functional validation of vascular integrity was conducted using dextran permeability assays to demonstrate the successful restriction of macromolecule leakage for multiple weeks. Furthermore, the vascular network exhibited increased permeability and angiogenesis in the presence of hepatic spheroids. We also determined the optimal media composition and procedure to culture spheroids made of primary hepatocytes. Incorporation into the Angioplate demonstrated improved functional output of the primary hepatic spheroids compared to static conditions revealed through measurements of albumin secretion. The bifurcating Angioplate offers the advantage in cost-effectiveness, scalability, and adaptability to vascularize spheroids. Further studies integrating additional relevant cell types, refining vascular stability, and incorporating automation methods for device assembly will enhance the reliability and potential for the platform in becoming a powerful tool for preclinical drug testing. | en_US |
dc.language.iso | en | en_US |
dc.subject | Microfluidics, liver, vasculature, spheroids, organ-on-a-chip, cell culture, in-vitro, biomaterials, 3D printing. | en_US |
dc.title | The Development of a Vascularized Liver-on-a-Chip Using Precise Hydrogel Micro-patterning Techniques | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Biomedical Engineering | en_US |
dc.description.degreetype | Thesis | en_US |
dc.description.degree | Master of Applied Science (MASc) | en_US |
dc.description.layabstract | The liver is the primary site for drug metabolism, and liver injury caused by drug toxicity remains a major challenge in medicine. Current drug testing methods using animal and traditional cell cultures often fail to predict harmful effects in humans due to cross-species differences in liver metabolism. To improve drug safety of cell cultures used in preclinical drug studies, “liver-on-a-chip” models are developed to advance to better mimic the microenvironment of the liver. This thesis presents a novel liver-on-a-chip device designed to position liver spheroids central to a functional bifurcating blood vessel network. This model aims to enhance the survival and function of liver tissue by incorporating controlled fluid flow and close interaction between endothelial and epithelial 3D cell structures to create a physiologically relevant liver microenvironment. The device is also designed for easy integration with existing cell culture equipment to streamline drug screening. In the future, this model could provide a more reliable tool for predicting liver toxicity and ultimately reduce the need for animal testing. | en_US |
Appears in Collections: | Open Access Dissertations and Theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Hollinger_Andrew_D_202508_MASc.pdf | 16.32 MB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.